Search Results for:
-
Other News To Note
Sigma-Tau Pharmaceuticals Inc., of Gaithersburg, Md., said the FDA approved Cystaran (cysteamine ophthalmic solution) 0.44 percent, a topical ophthalmic therapeutic developed in partnership with the National Institutes of Health, for the treatment of corneal cysteine crystal accumulation as a result of cystinosisBioWorld Today | Friday, October 5, 2012 -
Scientists Present Grand Unified Theory of C-Myc
Researchers from the National Institutes of Health, on the other hand, "used a mouse strain with green fluorescent protein knocked into the c-Myc locus," co-corresponding author Keji Zhao told BioWorld TodayBio Perspectives | Wednesday, October 3, 2012 -
Clinic Roundup
The study is evaluating the safety and efficacy of MultiStem in moderate to moderately severe stroke, as defined by a National Institutes of Health Stroke Scale score of 8 to 20BioWorld Today | Wednesday, October 3, 2012 -
Scientists Present Grand Unified Theory of C-Myc
Researchers from the National Institutes of Health, on the other hand, "used a mouse strain with green fluorescent protein knocked into the c-Myc locus," co-corresponding author Keji Zhao told BioWorld TodayBy Anette Breindl | BioWorld Today | Tuesday, October 2, 2012 -
OMB Urges Agencies to Ignore Sequestion, at Least for Now
According to an OMB report released last month, the National Institutes of Health (NIH) could lose more than $2.4 billion for fiscal year 2013, while the FDA could end up taking a hit of $319 million under sequestration. (See BioWorld Today, Sept. 10, 2012, and Sept. 17, 2012.) Those cuts could be catastrophic for the FDA, which already is facing uncertainty about its user feesBy Staff Reports | BioWorld Today | Tuesday, October 2, 2012 -
Other News To Note
Protein Potential LLC, of Rockville, Md., was awarded three Phase I Small Business Innovation Research grants totaling $1.8 million from the National Institutes of Health to develop a malaria vaccine that protects against Plasmodium falciparum, the malaria parasite responsible for more than 95 percent of malaria-associated deaths worldwideBioWorld Today | Thursday, September 27, 2012 -
PCAST to FDA: Double New Drug Output in 10 Years
Money Is Big Stumbling Block Across Spectrum Additional recommendations to achieve the admittedly ambitious goal of doubling new drug output over the next decade included "vigorous" federal government support for initiatives to accelerate therapeutics, such as the National Center for Advancing Translational Sciences at the National Institutes of Health (NIH) and the Reagan-Udall Foundation, and creation of a broad-based partnership to accelerate therapeutics by engaging a range of stakeholdersBy Marie Powers | BioWorld Today | Thursday, September 27, 2012 -
Galaxy Hooks Roche for Preclinical Oncology Program
Galaxy's FGF2 program was underwritten, in part, by Small Business Innovation Research grants from the National Institutes of HealthBy Marie Powers | BioWorld Today | Wednesday, September 26, 2012 -
Other News To Note
Evotec AG, of Hamburg, Germany, said it entered a multiyear compound management agreement with the National Institutes of Health (NIH), Department of Health and Human Services, for the operation of a Small Molecule RepositoryBioWorld International | Wednesday, September 26, 2012 -
Shutdown Avoided but Drug User Fee Impact is Unclear
The House passed HR 6163 Wednesday, creating a pediatric research network for rare diseases through the National Institutes of Health (NIHBio Perspectives | Tuesday, September 25, 2012 -
Other News To Note
Biodel Inc., of Danbury, Conn., said the National Institutes of Health's Small Business Innovation Research program awarded the firm a grant for the development of stable glucagon formulations for use in an artificial pancreas, also known as a closed loop pump systemBioWorld Today | Tuesday, September 25, 2012 -
Sequestration: Should Big Bird Be Fricasseed?
WASHINGTON – Rather than serve up across-the-board cuts mandated by sequestration that would slice deeply into the National Institutes of Health (NIH) budget, Congress needs to be more selective when carving out savings, RepBy Mark McCarty | BioWorld Today | Monday, September 24, 2012 -
Shutdown Avoided but Drug User Fee Impact is Unclear
The House passed HR 6163 Wednesday, creating a pediatric research network for rare diseases through the National Institutes of Health (NIHBy Catherine Shaffer | BioWorld Today | Monday, September 24, 2012 -
Other News To Note
Evotec AG, of Hamburg, Germany, said it entered a multiyear compound management agreement with the National Institutes of Health (NIH), Department of Health and Human Services, for the operation of a Small Molecule RepositoryBioWorld Today | Thursday, September 20, 2012 -
FDA Adcom: 'No Limits' on New Tumor Cell Lines in Vaccines
Obviously the agency needs to have that capacity, but so does each sponsor," said Pamela McInnes, director of the Division of Extramural Research for the National Institutes of HealthBy Catherine Shaffer | BioWorld Today | Thursday, September 20, 2012 -
Committee to Ponder Tumor Cells for Vaccine Manufacture
National Institutes of Health researchers discovered a mutation that increases production of red blood cells in tumors that may clarify the formation of the blood supply that sustains tumor growthBio Perspectives | Wednesday, September 19, 2012 -
Committee to Ponder Tumor Cells for Vaccine Manufacture
National Institutes of Health researchers discovered a mutation that increases production of red blood cells in tumors that may clarify the formation of the blood supply that sustains tumor growthBy Catherine Shaffer | BioWorld Today | Wednesday, September 19, 2012 -
Pieces of Federal Funding Puzzle Coming Together
By Mari Serebrov Washington Editor With one piece of the budget puzzle about to be put in place, at least temporarily, the FDA, National Institutes of Health (NIH) and other federal agencies can start planning for fiscal 2013, which begins in two weeksBio Perspectives | Tuesday, September 18, 2012 -
Other News To Note
America Stem Cell Inc. (ASC), of San Antonio, received an Advanced Technology Small Business Technology Transfer Research (STTR) grant from the National Heart Lung and Blood Institute at the National Institutes of HealthBioWorld Today | Tuesday, September 18, 2012 -
Pieces of Federal Funding Puzzle Coming Together
With one piece of the budget puzzle about to be put in place, at least temporarily, the FDA, National Institutes of Health (NIH) and other federal agencies can start planning for fiscal 2013, which begins in two weeksBy Mari Serebrov | BioWorld Today | Monday, September 17, 2012
Category
Current Filters
- xInstitutes of Health
Related Keywords
Categories
- x BioWorld Today (2969)
- x BioWorld International (239)
- x BioWorld Insight (221)
- x Bio Perspectives (104)
- x State of the Industry Report (32)
- x BioWorld Genomics Review (17)
- x Top 25 Drug Report (15)
- x RNAi Report (7)
- x BioWorld Snapshots (6)
- x Biotech Innovations (2)
- x Bioscan (1)
- x Recorded (1)
BioWorld | 3525 Piedmont Road
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Part of Thompson Media Group LLC
Free Ezine
Sign up for Perspectives FREE e-mail newsletter.
Customer Service: In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.